Cargando…

Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers

BACKGROUND: Natural products are a valuable source of biologically active compounds that have applications in medicine and agriculture. One disadvantage with natural products is the slow, time-consuming strain improvement regimes that are necessary to ensure sufficient quantities of target compounds...

Descripción completa

Detalles Bibliográficos
Autores principales: Pikl, Špela, Rincón, Andrés Felipe Carrillo, Slemc, Lucija, Goranovič, Dušan, Avbelj, Martina, Gjuračić, Krešimir, Sucipto, Hilda, Stare, Katja, Baebler, Špela, Šala, Martin, Guo, Meijin, Luzhetskyy, Andriy, Petković, Hrvoje, Magdevska, Vasilka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890619/
https://www.ncbi.nlm.nih.gov/pubmed/33596911
http://dx.doi.org/10.1186/s12934-021-01522-5
_version_ 1783652540156477440
author Pikl, Špela
Rincón, Andrés Felipe Carrillo
Slemc, Lucija
Goranovič, Dušan
Avbelj, Martina
Gjuračić, Krešimir
Sucipto, Hilda
Stare, Katja
Baebler, Špela
Šala, Martin
Guo, Meijin
Luzhetskyy, Andriy
Petković, Hrvoje
Magdevska, Vasilka
author_facet Pikl, Špela
Rincón, Andrés Felipe Carrillo
Slemc, Lucija
Goranovič, Dušan
Avbelj, Martina
Gjuračić, Krešimir
Sucipto, Hilda
Stare, Katja
Baebler, Špela
Šala, Martin
Guo, Meijin
Luzhetskyy, Andriy
Petković, Hrvoje
Magdevska, Vasilka
author_sort Pikl, Špela
collection PubMed
description BACKGROUND: Natural products are a valuable source of biologically active compounds that have applications in medicine and agriculture. One disadvantage with natural products is the slow, time-consuming strain improvement regimes that are necessary to ensure sufficient quantities of target compounds for commercial production. Although great efforts have been invested in strain selection methods, many of these technologies have not been improved in decades, which might pose a serious threat to the economic and industrial viability of such important bioprocesses. RESULTS: In recent years, introduction of extra copies of an entire biosynthetic pathway that encodes a target product in a single microbial host has become a technically feasible approach. However, this often results in minor to moderate increases in target titers. Strain stability and process reproducibility are the other critical factors in the industrial setting. Industrial Streptomyces rimosus strains for production of oxytetracycline are one of the most economically efficient strains ever developed, and thus these represent a very good industrial case. To evaluate the applicability of amplification of an entire gene cluster in a single host strain, we developed and evaluated various gene tools to introduce multiple copies of the entire oxytetracycline gene cluster into three different Streptomyces rimosus strains: wild-type, and medium and high oxytetracycline-producing strains. We evaluated the production levels of these engineered S. rimosus strains with extra copies of the oxytetracycline gene cluster and their stability, and the oxytetracycline gene cluster expression profiles; we also identified the chromosomal integration sites. CONCLUSIONS: This study shows that stable and reproducible increases in target secondary metabolite titers can be achieved in wild-type and in high oxytetracycline-producing strains, which always reflects the metabolic background of each independent S. rimosus strain. Although this approach is technically very demanding and requires systematic effort, when combined with modern strain selection methods, it might constitute a very valuable approach in industrial process development.
format Online
Article
Text
id pubmed-7890619
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78906192021-02-22 Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers Pikl, Špela Rincón, Andrés Felipe Carrillo Slemc, Lucija Goranovič, Dušan Avbelj, Martina Gjuračić, Krešimir Sucipto, Hilda Stare, Katja Baebler, Špela Šala, Martin Guo, Meijin Luzhetskyy, Andriy Petković, Hrvoje Magdevska, Vasilka Microb Cell Fact Research BACKGROUND: Natural products are a valuable source of biologically active compounds that have applications in medicine and agriculture. One disadvantage with natural products is the slow, time-consuming strain improvement regimes that are necessary to ensure sufficient quantities of target compounds for commercial production. Although great efforts have been invested in strain selection methods, many of these technologies have not been improved in decades, which might pose a serious threat to the economic and industrial viability of such important bioprocesses. RESULTS: In recent years, introduction of extra copies of an entire biosynthetic pathway that encodes a target product in a single microbial host has become a technically feasible approach. However, this often results in minor to moderate increases in target titers. Strain stability and process reproducibility are the other critical factors in the industrial setting. Industrial Streptomyces rimosus strains for production of oxytetracycline are one of the most economically efficient strains ever developed, and thus these represent a very good industrial case. To evaluate the applicability of amplification of an entire gene cluster in a single host strain, we developed and evaluated various gene tools to introduce multiple copies of the entire oxytetracycline gene cluster into three different Streptomyces rimosus strains: wild-type, and medium and high oxytetracycline-producing strains. We evaluated the production levels of these engineered S. rimosus strains with extra copies of the oxytetracycline gene cluster and their stability, and the oxytetracycline gene cluster expression profiles; we also identified the chromosomal integration sites. CONCLUSIONS: This study shows that stable and reproducible increases in target secondary metabolite titers can be achieved in wild-type and in high oxytetracycline-producing strains, which always reflects the metabolic background of each independent S. rimosus strain. Although this approach is technically very demanding and requires systematic effort, when combined with modern strain selection methods, it might constitute a very valuable approach in industrial process development. BioMed Central 2021-02-17 /pmc/articles/PMC7890619/ /pubmed/33596911 http://dx.doi.org/10.1186/s12934-021-01522-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pikl, Špela
Rincón, Andrés Felipe Carrillo
Slemc, Lucija
Goranovič, Dušan
Avbelj, Martina
Gjuračić, Krešimir
Sucipto, Hilda
Stare, Katja
Baebler, Špela
Šala, Martin
Guo, Meijin
Luzhetskyy, Andriy
Petković, Hrvoje
Magdevska, Vasilka
Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
title Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
title_full Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
title_fullStr Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
title_full_unstemmed Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
title_short Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
title_sort multiple copies of the oxytetracycline gene cluster in selected streptomyces rimosus strains can provide significantly increased titers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890619/
https://www.ncbi.nlm.nih.gov/pubmed/33596911
http://dx.doi.org/10.1186/s12934-021-01522-5
work_keys_str_mv AT piklspela multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT rinconandresfelipecarrillo multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT slemclucija multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT goranovicdusan multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT avbeljmartina multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT gjuracickresimir multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT suciptohilda multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT starekatja multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT baeblerspela multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT salamartin multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT guomeijin multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT luzhetskyyandriy multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT petkovichrvoje multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters
AT magdevskavasilka multiplecopiesoftheoxytetracyclinegeneclusterinselectedstreptomycesrimosusstrainscanprovidesignificantlyincreasedtiters